Parkinson’s Disease Therapeutics Market: The Influence of Personalized Medicine and Genetic Biomarkers.
Moving Beyond One-Size-Fits-All: The Need for Patient Stratification
Parkinson’s disease is now recognized as a heterogeneous disorder, meaning different underlying pathological mechanisms may dominate in different patients. This understanding is driving the shift toward personalized medicine, where treatment selection is guided by genetic and biological biomarkers. For example, patients...
0 التعليقات
0 المشاركات
18 مشاهدة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt